What Is Behind The Move In Elevance Health Stock?

ELVYTD+16.0%SPYYTD+7.9%XLVYTD+18.5%
Analyze ELV →

Today’s big story: Could Anthropic Stock Fall 25%?

Elevance Health (ELV) stock fell 7.6% on Wednesday, November 18, 2026, while the S&P 500 slipped 0.2%. The company issued no announcements, earnings reports or filings. Yet all seven other managed health care companies worth $2 billion or more fell during the same session. What sent the whole group lower, and which part of Elevance’s business does it touch?

Elevance Health fell 7.6% in one day, and all seven of its large peers fell with it. If most of your savings sits in this one stock, that drop hits your money even when the company did nothing wrong. In a free 30-minute review, our partner advisory firm can show you ways to limit your loss if the stock falls further and to sell with a smaller tax bill. Book the free review.

Image from Pixabay

What Pulled Elevance Health’s Group Lower?

UnitedHealth Group and other Medicare Advantage insurers fell on November 18 over a federal proposal. The proposal could let regulators recover Medicare Advantage overpayments dating back to 2018. Elevance sells Medicare Advantage plans too, so as a holder you own a piece of the business the proposal is about.

Those plans were still short of where management wants them. On its October 21 call, management said its Medicare Advantage plans are on track for an operating margin of at least 2% in 2026. That margin is the share of revenue left as operating profit. Its long-term target for that business is 3% to 5%, so the plans are still working their way toward it.

Elevance Health Fell With Its Whole Group

Elevance’s fall matched the 7.6% median drop of its peers in managed health care. All seven other companies in that group worth $2 billion or more fell. Six of them dropped 5% or more. Among its peers, Humana fell 13.0% and UnitedHealth Group 10.2%.

The health care sector fund, XLV, lost 2.2% during the same session. So Elevance and its group fell far more than health care as a whole.

Where Does Elevance Health Stock Stand Now?

A fall this large is not new for Elevance. The stock had three falls at least this big over the prior 365 days, with the latest arriving on July 15, 2026, when it dropped 8.5%.

Even after this one, the stock returned 23.5% over the past 12 months, against 11.0% for the S&P 500. Its 52-week closing high of $446.28 came on November 16, two days before the fall. Its 52-week closing low was $280.74, on March 9, 2026. Elevance trades at 0.43 times its sales over the last 12 months, against 3.1 times for the S&P 500.

Elevance is expected to report its fourth-quarter 2026 results in January 2027. That report will show how 2026 ended for its Medicare Advantage plans. Management also said on the October call that it will give more detail in January on its assumptions for 2027.

A day like this can come from news about other companies rather than the one you own. The market barely moved that day, so what helps is not having too much of your savings in one stock or one group.

Could You Hold On Through The Next Fall?

Holding on is easier when your portfolio falls less than the market. For every dollar its benchmark lost, the Trefis High Quality (HQ) Portfolio lost about 81 cents on average, holding 30 quality stocks in equal weight.

See How HQ Held Up

Spot an error or want more like this? Tell us in 10 seconds.